Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1967]

CPX-351 after stem cell transplant for elderly patients with AML

Prof Jeffery Lancet - H. Lee Moffitt Cancer Center, Tampa, USA

CPX-351 after stem cell transplant for elderly patients with AML ( Prof Jeffery Lancet - H. Lee Moffitt Cancer Center, Tampa, USA )

Involving young people in cancer research

Lorna Fern - Teenage and Young Adult Clinical Studies Group, NCRI, UK

Involving young people in cancer research ( Lorna Fern - Teenage and Young Adult Clinical Studies Group, NCRI, UK )

AML: Is less as good as more?

Dr Rebecca Olin - University of California San Francisco, San Francisco,, USA

AML: Is less as good as more? ( Dr Rebecca Olin - University of California San Francisco, San Francisco,, USA )

The creation of SIOG, and a systematic review of the AML literature

Dr Martine Extermann - Moffitt Cancer Center, Tampa, USA

The creation of SIOG, and a systematic review of the AML literature ( Dr Martine Extermann - Moffitt Cancer Center, Tampa, USA )

Multiple myeloma in the elderly

Prof Tanya Wildes - Washington University School of Medicine, St. Louis, USA

Multiple myeloma in the elderly ( Prof Tanya Wildes - Washington University School of Medicine, St. Louis, USA )

Using adoptive cell therapy to fight cancer

Prof Malcolm Brenner - Baylor College of Medicine, Houston, USA

Using adoptive cell therapy to fight cancer ( Prof Malcolm Brenner - Baylor College of Medicine, Houston, USA )

What does palbociclib do and what side effects might we see?

Dr Alison Jones - The LOC, London, UK

What does palbociclib do and what side effects might we see? ( Dr Alison Jones - The LOC, London, UK )

Overcoming painful bone disease in myeloma

Dr Nicola Giuliani - University of Parma, Parma, Italy

Overcoming painful bone disease in myeloma ( Dr Nicola Giuliani - University of Parma, Parma, Italy )

History and progress of CD38 in myeloma

Dr Fabio Malavasi - University of Turin, Turin, Italy

History and progress of CD38 in myeloma ( Dr Fabio Malavasi - University of Turin, Turin, Italy )

Maintenance therapy in young myeloma patients beneficial after autologous stem...

Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France

Maintenance therapy in young myeloma patients beneficial after autologous stem cell transplant ( Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France )

Better doctor-patient communication needed to improve myeloma outcomes

Dr Karthik Ramasamy - Oxford University Hospital, Oxford, UK

Better doctor-patient communication needed to improve myeloma outcomes ( Dr Karthik Ramasamy - Oxford University Hospital, Oxford, UK )

History of antiangiogenic drugs in multiple myeloma, starting with thalidomide

Dr Jens Hillengaß - UniversitätsKlinikum Heidelberg, Heidelberg, Germany

History of antiangiogenic drugs in multiple myeloma, starting with thalidomide ( Dr Jens Hillengaß - UniversitätsKlinikum Heidelberg, Heidelberg, Germany )

More from ecancer